Synopsis
Public Meeting on the Reauthorization of the Biosimilar User Fee Act (BsUFA) This webpage contains the meeting agenda and additional meeting materials.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at FDA: drugs ↗
